GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mankind Pharma Ltd (BOM:543904) » Definitions » Other Long-Term Liabilities

Mankind Pharma (BOM:543904) Other Long-Term Liabilities : ₹2,352 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Mankind Pharma Other Long-Term Liabilities?

Mankind Pharma's other long-term liabilities for the quarter that ended in Mar. 2024 was ₹2,352 Mil.

Mankind Pharma's quarterly other long-term liabilities declined from Sep. 2023 (₹3,075 Mil) to Dec. 2023 (₹0 Mil) but then increased from Dec. 2023 (₹0 Mil) to Mar. 2024 (₹2,352 Mil).

Mankind Pharma's annual other long-term liabilities declined from Mar. 2022 (₹758 Mil) to Mar. 2023 (₹0 Mil) but then increased from Mar. 2023 (₹0 Mil) to Mar. 2024 (₹2,352 Mil).

Mankind Pharma Other Long-Term Liabilities Historical Data

The historical data trend for Mankind Pharma's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mankind Pharma Other Long-Term Liabilities Chart

Mankind Pharma Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Other Long-Term Liabilities
- - - - -

Mankind Pharma Quarterly Data
Mar20 Mar21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Mankind Pharma Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Mankind Pharma Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Mankind Pharma's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Mankind Pharma (BOM:543904) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mankind Pharma Ltd (BOM:543904) » Definitions » Other Long-Term Liabilities
Comparable Companies
NSE:TORNTPHARM BOM:532321 BOM:500257 BOM:500124 NSE:AUROPHARMA NSE:DIVISLAB NSE:ALKEM BOM:524494 BOM:532331 BOM:506943 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
MANKIND:India
Address
262, Okhla Industrial Estate, Phase-III, New Delhi, IND, 110020
Website
https://www.mankindpharma.com
Mankind Pharma Ltd is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It operates at the intersection of Indian pharmaceutical formulations and consumer healthcare sectors with the aim of providing quality products at affordable prices and has an established track record of building and scaling brands in-house. The company's brands include Manforce, Prega News and Gas-O-Fast.

Mankind Pharma (BOM:543904) Headlines

No Headlines